# Effects of the Contraceptive Implant in Women With Sickle Cell Disease

> **NCT05730205** · PHASE4 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 22 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Nexplanon 68 MG Drug Implant

## Key facts

- **NCT ID:** NCT05730205
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-08
- **Primary completion:** 2026-06-15
- **Final completion:** 2026-06-15
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05730205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05730205, "Effects of the Contraceptive Implant in Women With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05730205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*